Viking Therapeutics (VKTX) Misses Q4 EPS by 48c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($1.38), $0.48 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• Corning (GLW) files for up to $2B offering of common shares
• AstraZeneca's camizestrant fails primary endpoint in breast cancer trial